• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食中的碳水化合物和脂肪会导致小鼠的表面活性剂发生明显改变。

Dietary Carbohydrates and Fat Induce Distinct Surfactant Alterations in Mice.

机构信息

Institute of Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany.

Biomedical Research in Endstage and Obstructive Lung Disease-Hannover, German Center for Lung Research, Hannover, Germany.

出版信息

Am J Respir Cell Mol Biol. 2021 Mar;64(3):379-390. doi: 10.1165/rcmb.2020-0335OC.

DOI:10.1165/rcmb.2020-0335OC
PMID:33351709
Abstract

Obesity and type 2 diabetes are nutrition-related conditions associated with lung function impairment and pulmonary diseases; however, the underlying pathomechanisms are incompletely understood. Pulmonary surfactant is essential for lung function, and surfactant synthesis by AT2 (alveolar epithelial type 2) cells relies on nutrient uptake. We hypothesized that dietary amounts of carbohydrates or fat affect surfactant homeostasis and composition. Feeding mice a starch-rich diet (StD), sucrose-rich diet (SuD), or fat-rich diet (FaD) for 30 weeks resulted in hypercholesterolemia and hyperinsulinemia compared with a fiber-rich control diet. In SuD and FaD groups, lung mechanic measurements revealed viscoelastic changes during inspiration, indicating surfactant alterations, and interfacial adsorption of isolated surfactant at the air-liquid interface was decreased under FaD. The composition of characteristic phospholipid species was modified, including a shift from dipalmitoyl-phosphatidylcholine (PC16:0/16:0) to palmitoyl-palmitoleoyl-phosphatidylcholine (PC16:0/16:1) in response to carbohydrates and decreased myristic acid-containing phosphatidylcholine species (PC14:0/14:0; PC16:0/14:0) on excess fat intake, as well as higher palmitoyl-oleoyl-phosphatidylglycerol (PG16:0/18:1) and palmitoyl-linoleoyl-phosphatidylglycerol (PG16:0/18:2) fractions in StD, SuD, and FaD groups than in the control diet. Moreover, mRNA expression levels of surfactant synthesis-related proteins within AT2 cells were altered. Under the StD regimen, AT2 cells showed prominent lipid accumulations and smaller lamellar bodies. Thus, in an established mouse model, distinct diet-related surfactant alterations were subtle, yet detectable, and may become challenging under conditions of reduced respiratory capacity. Dietary fat was the only macronutrient significantly affecting surfactant function. This warrants future studies examining alimentary effects on lung surfactant, with special regard to pulmonary complications in obesity and type 2 diabetes.

摘要

肥胖症和 2 型糖尿病是与肺功能损害和肺部疾病相关的营养相关病症;然而,潜在的发病机制尚不完全清楚。肺表面活性剂对于肺功能至关重要,而 AT2(肺泡上皮 2 型)细胞合成肺表面活性剂依赖于营养物质的摄取。我们假设碳水化合物或脂肪的饮食含量会影响肺表面活性剂的动态平衡和组成。用富含淀粉的饮食(StD)、富含蔗糖的饮食(SuD)或富含脂肪的饮食(FaD)喂养小鼠 30 周,与富含纤维的对照饮食相比,会导致高胆固醇血症和高胰岛素血症。在 SuD 和 FaD 组中,肺力学测量显示吸气时出现粘弹性变化,表明肺表面活性剂发生改变,并且 FaD 下分离的肺表面活性剂在气液界面的界面吸附减少。特征磷脂种类的组成发生改变,包括二棕榈酰磷脂酰胆碱(PC16:0/16:0)向棕榈酰-油酰磷脂酰胆碱(PC16:0/16:1)的转移,以及在碳水化合物过量摄入时,富含肉豆蔻酸的磷脂种类(PC14:0/14:0;PC16:0/14:0)减少,以及 StD、SuD 和 FaD 组中棕榈酰-油酰-磷脂酰甘油(PG16:0/18:1)和棕榈酰-亚油酰-磷脂酰甘油(PG16:0/18:2)的比例增加,而对照饮食中则没有。此外,AT2 细胞中与肺表面活性剂合成相关的蛋白质的 mRNA 表达水平也发生了改变。在 StD 方案下,AT2 细胞表现出明显的脂质积累和较小的板层小体。因此,在已建立的小鼠模型中,不同的饮食相关肺表面活性剂改变虽然细微,但却可以检测到,并且在呼吸能力降低的情况下可能会变得具有挑战性。膳食脂肪是唯一显著影响肺表面活性剂功能的宏量营养素。这需要未来的研究来检查饮食对肺表面活性剂的影响,特别关注肥胖症和 2 型糖尿病的肺部并发症。

相似文献

1
Dietary Carbohydrates and Fat Induce Distinct Surfactant Alterations in Mice.饮食中的碳水化合物和脂肪会导致小鼠的表面活性剂发生明显改变。
Am J Respir Cell Mol Biol. 2021 Mar;64(3):379-390. doi: 10.1165/rcmb.2020-0335OC.
2
Increased palmitoyl-myristoyl-phosphatidylcholine in neonatal rat surfactant is lung specific and correlates with oral myristic acid supply.新生鼠肺表面活性物质中棕榈酰肉豆蔻酰磷脂酰胆碱增加具有肺特异性,并与口服肉豆蔻酸供应相关。
J Appl Physiol (1985). 2011 Aug;111(2):449-57. doi: 10.1152/japplphysiol.00766.2010. Epub 2011 Jun 2.
3
Myristate is selectively incorporated into surfactant and decreases dipalmitoylphosphatidylcholine without functional impairment.肉豆蔻酸选择性地掺入到表面活性剂中,且不会导致功能障碍,从而减少二棕榈酰磷脂酰胆碱。
Am J Physiol Regul Integr Comp Physiol. 2010 Nov;299(5):R1306-16. doi: 10.1152/ajpregu.00380.2010. Epub 2010 Sep 1.
4
Lung surfactant: Function and composition in the context of development and respiratory physiology.肺表面活性物质:发育与呼吸生理学背景下的功能与组成
Ann Anat. 2016 Nov;208:146-150. doi: 10.1016/j.aanat.2016.08.003. Epub 2016 Sep 29.
5
Lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome.致死性甲型H1N1流感病毒感染会改变小鼠肺泡II型细胞表面活性物质脂质组。
Am J Physiol Lung Cell Mol Physiol. 2016 Dec 1;311(6):L1160-L1169. doi: 10.1152/ajplung.00339.2016. Epub 2016 Nov 11.
6
The lipid transporter Mfsd2a maintains pulmonary surfactant homeostasis.脂质转运蛋白 Mfsd2a 维持肺表面活性剂的动态平衡。
J Biol Chem. 2022 Mar;298(3):101709. doi: 10.1016/j.jbc.2022.101709. Epub 2022 Feb 10.
7
Phosphatidylcholine molecular species in lung surfactant: composition in relation to respiratory rate and lung development.肺表面活性物质中的磷脂酰胆碱分子种类:与呼吸频率和肺发育相关的组成
Am J Respir Cell Mol Biol. 2001 Dec;25(6):725-31. doi: 10.1165/ajrcmb.25.6.4616.
8
Endogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammation.内源性 LXR 信号通路控制肺表面活性剂的动态平衡,防止肺部炎症。
Cell Mol Life Sci. 2024 Jul 6;81(1):287. doi: 10.1007/s00018-024-05310-3.
9
GCN5L1 regulates pulmonary surfactant production by modulating lamellar body biogenesis and trafficking in mouse alveolar epithelial cells.GCN5L1 通过调节小鼠肺泡上皮细胞的板层小体发生和转运来调节肺表面活性剂的产生。
Cell Mol Biol Lett. 2023 Nov 7;28(1):90. doi: 10.1186/s11658-023-00506-0.
10
A comparison of the molecular species compositions of mammalian lung surfactant phospholipids.哺乳动物肺表面活性物质磷脂的分子种类组成比较。
Comp Biochem Physiol A Mol Integr Physiol. 2001 May;129(1):65-73. doi: 10.1016/s1095-6433(01)00306-3.

引用本文的文献

1
High fat diet obesity exacerbates acute lung injury induced dysregulation of fatty acid oxidation in alveolar epithelial type 2 cells.高脂饮食诱导的肥胖会加剧急性肺损伤所致的肺泡Ⅱ型上皮细胞脂肪酸氧化失调。
Am J Physiol Lung Cell Mol Physiol. 2025 Jul 22. doi: 10.1152/ajplung.00406.2024.
2
Sucrose- and fat-related metabolic states influence the adaptation of the pulmonary lipid metabolism to hypoxia.蔗糖和脂肪相关的代谢状态影响肺脂质代谢对缺氧的适应性。
Cell Tissue Res. 2025 Apr 1. doi: 10.1007/s00441-025-03968-0.
3
PPARG/SPP1/CD44 signaling pathway in alveolar macrophages: Mechanisms of lipid dysregulation and therapeutic targets in idiopathic pulmonary fibrosis.
肺泡巨噬细胞中的PPARG/SPP1/CD44信号通路:特发性肺纤维化中脂质失调的机制及治疗靶点
Heliyon. 2025 Jan 2;11(1):e41628. doi: 10.1016/j.heliyon.2025.e41628. eCollection 2025 Jan 15.
4
Magnitude of obesity alone does not alter the alveolar lipidome.肥胖的严重程度并不能改变肺泡的脂质组。
Am J Physiol Lung Cell Mol Physiol. 2024 Nov 1;327(5):L615-L623. doi: 10.1152/ajplung.00112.2024. Epub 2024 Sep 10.
5
Preoperative Atelectasis in Patients with Obesity Undergoing Bariatric Surgery: A Cross-Sectional Study.肥胖症患者接受减肥手术时的术前肺不张:一项横断面研究。
Anesth Analg. 2024 Aug 23;140(6):1450-60. doi: 10.1213/ANE.0000000000007166.
6
Postnatal growth restriction impairs rat lung structure and function.出生后生长受限会损害大鼠的肺结构和功能。
Anat Rec (Hoboken). 2025 Apr;308(4):1051-1065. doi: 10.1002/ar.25297. Epub 2023 Jul 28.
7
Type 1 diabetes and diet-induced obesity predispose C57BL/6J mice to PM-induced lung injury: a comparative study.1 型糖尿病和饮食诱导肥胖使 C57BL/6J 小鼠易患 PM 诱导的肺损伤:一项比较研究。
Part Fibre Toxicol. 2023 Apr 17;20(1):10. doi: 10.1186/s12989-023-00526-w.
8
Oral Supplementation with the Polyamine Spermidine Affects Hepatic but Not Pulmonary Lipid Metabolism in Lean but Not Obese Mice.口服补充多胺精胺影响 lean 但不肥胖小鼠的肝脂代谢但不影响肺脂代谢。
Nutrients. 2022 Oct 15;14(20):4318. doi: 10.3390/nu14204318.
9
Starch and Fiber Contents of Purified Control Diets Differentially Affect Hepatic Lipid Homeostasis and Gut Microbiota Composition.纯化对照饮食中的淀粉和纤维含量对肝脏脂质稳态和肠道微生物群组成有不同影响。
Front Nutr. 2022 Jul 7;9:915082. doi: 10.3389/fnut.2022.915082. eCollection 2022.
10
A recipe for a good clinical pulmonary surfactant.一种好的临床用肺表面活性剂的配方。
Biomed J. 2022 Aug;45(4):615-628. doi: 10.1016/j.bj.2022.03.001. Epub 2022 Mar 8.